Come up with a name for your new list and we'll add to it:
C.R. Bard raised a round of funding on December 29, 2017. Investors include
Becton Dickinson and Company.
C. R. Bard (NYSE: BCR), is a leading multinational developer, manufacturer, and marketer of innovative, life-enhancing medical technologies in the fields of Vascular, Urology, Oncology, and Surgical S…